secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001193125-23-173133
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Nicholas Haft resigns from Finch Therapeutics Board effective June 23, 2023
--------------------------------------------------------------------------------

- Nicholas Haft resigned from the Board, effective June 23, 2023.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- Board composition changes following Haft's departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523173133/0001193125-23-173133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523173133/d682099d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-173133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer